Gardner Lewis Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Gardner Lewis Asset Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,002,214	Closed	-$2.32M	–	97
2022 Q2	$2.32M	Buy	2,002,214 +1,292,985	+182%	+$1.35M	0.47%	55
2022 Q1	$766K	Buy	+709,229	New	+$536K	0.14%	68

Gardner Lewis Asset Management's MBII Position: Q3 2022 in Review

Gardner Lewis Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 2,002,214 shares — an estimated $2.32M sold.

Gardner Lewis Asset Management first reported a position in MBII in Q1 2022 and held it in 2 quarters. The position peaked at $2.32M in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Gardner Lewis Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 2,002,214 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $2.32M.
Gardner Lewis Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q1 2022 and held it in 2 quarters.
Gardner Lewis Asset Management's Marrone Bio Innovations, Inc. position peaked at $2.32M in Q2 2022.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.